Our Opinion

Barinthus Biotherapeutics plc is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company mentioned on its website that it uses animals for product testing.

“Enhanced APC uptake together with co-delivered immunomodulator promote increased T regulatory (Treg)/T effector (Teff) cell ratio associated with efficacy in animal models of vitiligo, type 1 diabetes and experimental autoimmune encephalomyelitis.” Read the following article

Company Description

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in development of novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Didcot, the United Kingdom.

Company Website: https://www.barinthusbio.com